Case Control Study
Copyright ©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Nov 6, 2017; 8(4): 193-200
Published online Nov 6, 2017. doi: 10.4292/wjgpt.v8.i4.193
Table 2 Genotype and allele frequencies of rs2910164, rs11614913, and rs188519172 polymorphisms in Crohn’s disease patients according to response to anti-TNF treatment
GenotypeComplete responders (n = 72)Partial responders (n = 22)P value; OR (95%CI)Non-responders (n = 13)P value; OR (95%CI)
miR-146a, rs2910164
GG70 (97.22)21 (95.45)1.0 (reference)12 (92.31)1.0 (reference)
GC2 (2.78)1 (4.54)0.55; 1.67 (0.14-19.32)1 (7.69)0.39; 2.92 (0.25-34.76)
CC00-0-
miR-196a, rs11614913
CC33 (45.83)5 (22.73)1.0 (reference)5 (38.46)1.0 (reference)
CT32 (44.45)13 (59.09)0.11; 2.7 (0.86-8.39)5 (38.46)1.0; 1.03 (0.27-3.91)
TT7 (9.73)4 (18.18)0.18; 3.78 (0.8-17.73)3 (23.08)0.34; 2.83 (0.54-14.69)
miR-224, rs188519172
AA38 (52.78)9 (40.9)1.0 (reference)7 (53.84)1.0 (reference)
AG29 (40.28)11 (50)0.44; 1.60 (0.59-4.37)4 (30.76)0.75; 0.75 (0.20-2.80
GG5 (6.94)2 (9.09)0.62; 1.69 (0.28-10.16)2 (15.38)0.59; 2.17 (0.35-13.51)